Neuroprotective agents for clinical trials in Parkinson’s disease: a systematic assessment.
E. Diguet, C. E. Gross, E. Bezard, F. Tison, N. Stefanova, G. K. Wenning, B. Ravina, S. Fagan, R. Hart, C. Hovinga, D. Murphy, T. Dawson, J. Marler
Neurology. 2004-01-12; 62(1): 158-159
DOI: 10.1212/wnl.62.1.158

Read on PubMed
Neurology. 2004-01-12; 62(1): 158-159
DOI: 10.1212/wnl.62.1.158

Read on PubMed